Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells

Cell Mol Biol Lett. 2020 Mar 10:25:17. doi: 10.1186/s11658-020-00208-x. eCollection 2020.

Abstract

Background: High levels of the post-translational modification O-GlcNAcylation (O-GlcNAc) are found in multiple cancers, including bladder cancer. Autophagy, which can be induced by stress from post-translational modifications, plays a critical role in maintaining cellular homeostasis and regulating tumorigenesis. The impact of O-GlcNAcylation on autophagy in bladder cancer remains unclear. Here, we evaluate the change in autophagic activity in response to O-GlcNAcylation and explore the potential mechanisms.

Methods: O-GlcNAcylation levels in bladder cancer cells were altered through pharmacological or genetic manipulations: treating with 6-diazo-5-oxo-norleucine (DON) or thiamet-G (TG) or up- and downregulation of O-GlcNAc transferase (OGT) or O-GlcNAcase (OGA). Autophagy was determined using fluorescence microscopy and western blotting. Co-immunoprecipitation (Co-IP) assays were performed to evaluate whether the autophagy regulator AMP-activated protein kinase (AMPK) was O-GlcNAc modified.

Results: Cellular autophagic flux was strikingly enhanced as a result of O-GlcNAcylation suppression, whereas it decreased at high O-GlcNAcylation levels. Phosphorylation of AMPK increased after the suppression of O-GlcNAcylation. We found that O-GlcNAcylation of AMPK suppressed the activity of this regulator, thereby inhibiting ULK1 activity and autophagy.

Conclusion: We characterized a new function of O-GlcNAcylation in the suppression of autophagy via regulation of AMPK.

Graphical abstract: Blockage of O-linked GlcNAcylation induces AMPK dependent autophagy in bladder cancer cells.

Keywords: AMPK; Autophagy; O-GlcNAcylation; ULK1.

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Acylation / drug effects
  • Acylation / genetics
  • Autophagy / drug effects
  • Autophagy / genetics*
  • Autophagy-Related Protein-1 Homolog / genetics
  • Autophagy-Related Protein-1 Homolog / metabolism
  • Azo Compounds / pharmacology
  • Cell Line, Tumor
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism
  • N-Acetylglucosaminyltransferases / genetics
  • N-Acetylglucosaminyltransferases / metabolism*
  • Norleucine / analogs & derivatives
  • Norleucine / pharmacology
  • Phosphorylation
  • Protein Processing, Post-Translational / drug effects*
  • Protein Processing, Post-Translational / genetics
  • Pyrans / pharmacology
  • RNA, Small Interfering
  • Thiazoles / pharmacology
  • Urinary Bladder Neoplasms / enzymology
  • Urinary Bladder Neoplasms / genetics
  • Urinary Bladder Neoplasms / metabolism*
  • beta-N-Acetylhexosaminidases / genetics
  • beta-N-Acetylhexosaminidases / metabolism*

Substances

  • Azo Compounds
  • Intracellular Signaling Peptides and Proteins
  • Pyrans
  • RNA, Small Interfering
  • Thiazoles
  • thiamet G
  • Norleucine
  • N-Acetylglucosaminyltransferases
  • Autophagy-Related Protein-1 Homolog
  • ULK1 protein, human
  • AMP-Activated Protein Kinases
  • hexosaminidase C
  • beta-N-Acetylhexosaminidases
  • 6-diazo-5-oxonorleucine